Access
To read this story in full you will need to login or make a payment (see right).
Insight
Nature 441, 423 (25 May 2006) | doi:10.1038/441423a; Published online 24 May 2006
nature jobs
Developer - Variation (Bioinformatician)
- European Bioinformatics Institute (EBI)
- Cambridge CB10 1SD United Kingdom
Chair
- McMaster University
- Hamilton, Canada
Introduction Signalling in cancer
The past 30 years have led from the discovery of the first cancer-causing gene, or 'oncogene', to the emergence of a new generation of cancer therapies — those targeted at specific signalling molecules.The signalling pathways controlling cell growth and differentiation are almost invariably altered in cancer.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
